STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

The official mascots of Pharmalot campus began their day by chasing cats, squirrels, and other creatures. Meanwhile, vehicles passed nearby en route to unknown destinations, while reporters prepared their daily dose of stimulating news. Today's featured story is the witch's potion, an intriguing topic sure to captivate readers.

The Trump administration's drug pricing policy has been hailed as a success, with every U.S. state agreeing to participate in a federal initiative to provide lower prices to Medicaid programs. However, some states remain undecided on whether to join, even though they have officially applied. More importantly, the specifics of what states could gain from the GENEROUS model, the federal initiative, are not publicly disclosed.

Heidi Overton, the Trump administration nominee to lead the U.S. Food and Drug Administration, is set to testify before a Senate committee. The hearing is expected to provide further insight into Overton's nomination, and if confirmed, she would become the youngest FDA commissioner in history at just 37 years old. To learn more about her remarkable journey from a young doctor in rural New Mexico to her current status as a nominee, continue reading STAT+.